BriaCell Therapeutics (BCTXW) Competitors $0.09 -0.01 (-10.87%) As of 12:48 PM Eastern This is a fair market value price provided by Polygon.io. Learn more. Add Compare Share Share Competitors Stock AnalysisChartCompetitorsFinancialsHeadlinesSEC FilingsShort InterestTrendsBuy This Stock BCTXW vs. ATNFW, LBPSW, AARD, AEHAW, AIMDW, ALVOW, ACABW, BFRIW, BTMDW, and CALAShould you be buying BriaCell Therapeutics stock or one of its competitors? The main competitors of BriaCell Therapeutics include 180 Life Sciences (ATNFW), 4D pharma (LBPSW), Aardvark Therapeutics (AARD), Aesther Healthcare Acquisition (AEHAW), Ainos (AIMDW), Alvotech (ALVOW), Atlantic Coastal Acquisition Corp. II (ACABW), Biofrontera (BFRIW), biote (BTMDW), and Calithera Biosciences (CALA). These companies are all part of the "pharmaceutical products" industry. BriaCell Therapeutics vs. 180 Life Sciences 4D pharma Aardvark Therapeutics Aesther Healthcare Acquisition Ainos Alvotech Atlantic Coastal Acquisition Corp. II Biofrontera biote Calithera Biosciences BriaCell Therapeutics (NASDAQ:BCTXW) and 180 Life Sciences (NASDAQ:ATNFW) are both medical companies, but which is the superior stock? We will compare the two companies based on the strength of their valuation, dividends, profitability, earnings, risk, analyst recommendations, community ranking, media sentiment and institutional ownership. Is BCTXW or ATNFW more profitable? Company Net Margins Return on Equity Return on Assets BriaCell TherapeuticsN/A N/A N/A 180 Life Sciences N/A N/A N/A Which has better earnings & valuation, BCTXW or ATNFW? CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioBriaCell TherapeuticsN/AN/AN/AN/AN/A180 Life SciencesN/AN/AN/AN/AN/A Does the media refer more to BCTXW or ATNFW? In the previous week, BriaCell Therapeutics had 2 more articles in the media than 180 Life Sciences. MarketBeat recorded 2 mentions for BriaCell Therapeutics and 0 mentions for 180 Life Sciences. 180 Life Sciences' average media sentiment score of 1.89 beat BriaCell Therapeutics' score of 1.28 indicating that 180 Life Sciences is being referred to more favorably in the news media. Company Overall Sentiment BriaCell Therapeutics Positive 180 Life Sciences Very Positive Does the MarketBeat Community favor BCTXW or ATNFW? BriaCell Therapeutics and 180 Life Sciences both received 0 outperform votes by MarketBeat users. CompanyUnderperformOutperformBriaCell TherapeuticsN/AN/A180 Life SciencesN/AN/A SummaryBriaCell Therapeutics and 180 Life Sciences tied by winning 1 of the 2 factors compared between the two stocks. Remove Ads Get BriaCell Therapeutics News Delivered to You Automatically Sign up to receive the latest news and ratings for BCTXW and its competitors with MarketBeat's FREE daily newsletter. Email Address New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding {thisCompany.Symbol} and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart BCTXW vs. The Competition Export to ExcelMetricBriaCell TherapeuticsBiotechnology IndustryMedical SectorNASDAQ ExchangeMarket CapN/A$115.04M$5.55B$7.86BDividend YieldN/A3.69%5.35%4.05%P/E RatioN/A3.1523.4918.67Price / SalesN/A4,117.09368.1387.32Price / CashN/A13.0138.1634.64Price / BookN/A35.646.634.09Net IncomeN/A-$87.82M$3.20B$246.93M7 Day PerformanceN/A-4.60%-6.38%-3.79%1 Month PerformanceN/A58.27%-1.52%-6.75%1 Year PerformanceN/A82.70%7.30%-1.88% BriaCell Therapeutics Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)BCTXWBriaCell TherapeuticsN/A$0.09-10.9%N/A-92.4%$0.00N/A0.008Positive NewsGap DownATNFW180 Life SciencesN/A$0.01+6.1%N/A-2.4%$0.00N/A0.007Positive NewsLBPSW4D pharmaN/AN/AN/AN/A$0.00$522,000.000.00N/AAARDAardvark TherapeuticsN/A$9.24-6.8%$30.50+230.1%N/A$0.00N/A0.0018Analyst ForecastNews CoverageAEHAWAesther Healthcare AcquisitionN/A$0.02+0.5%N/A-92.1%$0.00N/A0.002Gap UpAIMDWAinosN/A$0.11-34.3%N/A+71.1%$0.00$20,729.000.0040Gap DownALVOWAlvotechN/A$2.61-10.0%N/A-54.2%$0.00$391.87M0.004Short Interest ↓Positive NewsGap DownACABWAtlantic Coastal Acquisition Corp. IIN/A$0.03flatN/AN/A$0.00N/A0.0015BFRIWBiofronteraN/A$0.09+66.9%N/A-10.9%$0.00$35.36M0.0070Positive NewsGap DownHigh Trading VolumeBTMDWbioteN/A$0.07flatN/A-88.1%$0.00$197.19M0.00N/ACALACalithera BiosciencesN/AN/AN/AN/A$0.00N/A0.0060Analyst Forecast Remove Ads Related Companies and Tools Related Companies 180 Life Sciences Competitors 4D pharma Competitors Aardvark Therapeutics Competitors Aesther Healthcare Acquisition Competitors Ainos Competitors Alvotech Competitors Atlantic Coastal Acquisition Corp. II Competitors Biofrontera Competitors biote Competitors Calithera Biosciences Competitors Top 10 Stock Comparisons Semiconductor Stocks Artificial Intelligence Stocks Growth Stocks Magnificent Seven Stocks Pharmaceutical Stocks Ecommerce Stocks Bitcoin Stocks Meme Stocks Cryptocurrency Stocks Cybersecurity Stocks This page (NASDAQ:BCTXW) was last updated on 4/1/2025 by MarketBeat.com Staff From Our PartnersTrump’s Secret WeaponHave you looked at the stock market recently? Millions of investors are scrambling trying to figure out what's...American Alternative | SponsoredA market crash is coming—here’s whenThe stock market cycle I've used to identify the most likely day of the next market crash is the exact same in...Chaikin Analytics | SponsoredTrump Allies Confirm Exec Order 14024 Triggers Dollar CollapseExecutive Order 14024 is paving the way for irreversible damage to the dollar's value—threatening your wealth,...Priority Gold | SponsoredElon Musk Confirms: Tesla’s Optimus is Replacing Workers… and Heading to MarsMusk confirmed that SpaceX's Starship will carry Optimus to Mars in 2026 as part of an autonomous mission to h...InvestorPlace | SponsoredRetirement Nightmare? It’s Already Happening.The market is on edge. Every day, another company slashes its dividend, leaving investors scrambling. Intel...Investors Alley | SponsoredNew “Trump” currency proposed in DCA former U.S. Presidential Advisor has come forward with a stern warning to investors: “Get out of tech, no...Paradigm Press | Sponsored10X Bigger than AI, quantum, EVs, crypto, and robotics combined?World Economic Forum: "Arguably the Most Exciting Human Discovery Since Fire" Sam Altman, Bill Gates, and M...Stansberry Research | SponsoredIs Fort Knox Hiding Less Gold Than We Think? Find Out What That Means for YouWith gold prices recently soaring to record highs over $3,000 an ounce, and central banks rushing to accumulat...The Oxford Club | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding BriaCell Therapeutics Corp. Please log in to your account or sign up in order to add this asset to your watchlist. Share BriaCell Therapeutics With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
